Covered recipient · General Payments record
REBECCA R DUFF
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2018–2024
$1,443.00
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $299.14 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $139.64 | 8 |
| REVANCE THERAPEUTICS, INC. | $87.90 | 5 |
| TELA Bio, Inc. | $27.83 | 2 |
| GE HEALTHCARE | $22.92 | 1 |
| Hill Dermaceuticals, Inc. | $20.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.00 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664056 | CMS |
| ABBVIE INC. | $2.54 | 05/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664058 | CMS |
| ABBVIE INC. | $6.66 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664060 | CMS |
| ABBVIE INC. | $6.70 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664062 | CMS |
| ABBVIE INC. | $29.07 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664064 | CMS |
| ABBVIE INC. | $28.82 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664066 | CMS |
| ABBVIE INC. | $24.13 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664068 | CMS |
| ABBVIE INC. | $25.72 | 12/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103664070 | CMS |
| GE HEALTHCARE | $22.92 | 09/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144687358 | CMS |
| Hill Dermaceuticals, Inc. | $20.85 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1065461407 | CMS |
| REVANCE THERAPEUTICS, INC. | $15.72 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147916815 | CMS |
| REVANCE THERAPEUTICS, INC. | $22.34 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147916817 | CMS |
| REVANCE THERAPEUTICS, INC. | $15.66 | 07/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147916819 | CMS |
| REVANCE THERAPEUTICS, INC. | $16.55 | 08/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147916821 | CMS |
| REVANCE THERAPEUTICS, INC. | $17.63 | 09/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147916823 | CMS |
| TELA Bio, Inc. | $14.14 | 04/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154270109 | CMS |
| TELA Bio, Inc. | $13.69 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154270111 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.